Elevated Asymmetric Dimethylarginine is Associated With Oxidant Stress Aggravation in Patients With Early Stage Autosomal Dominant Polycystic Kidney Disease

Background/Aims: In experimental models of polycystic kidney disease impaired bioavailability of nitric oxide (NO) and elevated mRNA expression of oxidative stress markers at the kidney level was noted. However, clinical studies investigating the potential role of endothelial dysfunction and oxidati...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Vassilios Raptis (Autor), Panagiotis I. Georgianos (Autor), Pantelis A. Sarafidis (Autor), Athanasios Sioulis (Autor), Kali Makedou (Autor), Areti Makedou (Autor), Dimitrios M. Grekas (Autor), Stergios Kapoulas (Autor)
Format: Knjiga
Izdano: Karger Publishers, 2014-02-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_bca5a07d6ae64e8a9f16a3f115e4d795
042 |a dc 
100 1 0 |a Vassilios Raptis  |e author 
700 1 0 |a Panagiotis I. Georgianos  |e author 
700 1 0 |a Pantelis A. Sarafidis  |e author 
700 1 0 |a Athanasios Sioulis  |e author 
700 1 0 |a Kali Makedou  |e author 
700 1 0 |a Areti Makedou  |e author 
700 1 0 |a Dimitrios M. Grekas  |e author 
700 1 0 |a Stergios Kapoulas  |e author 
245 0 0 |a Elevated Asymmetric Dimethylarginine is Associated With Oxidant Stress Aggravation in Patients With Early Stage Autosomal Dominant Polycystic Kidney Disease 
260 |b Karger Publishers,   |c 2014-02-01T00:00:00Z. 
500 |a 1420-4096 
500 |a 1423-0143 
500 |a 10.1159/000355756 
520 |a Background/Aims: In experimental models of polycystic kidney disease impaired bioavailability of nitric oxide (NO) and elevated mRNA expression of oxidative stress markers at the kidney level was noted. However, clinical studies investigating the potential role of endothelial dysfunction and oxidative stress in the pathogenesis of autosomal dominant polycystic kidney disease (ADPKD) are limited. We evaluated asymmetric dimethylarginine (ADMA) as marker of NO synthase inhibitor as well as 15-F2t-Isoprostane and oxidized-low density lipoprotein (oxidized-LDL) as measures of oxidative stress in patients with early stages ADPKD. Methods: We recruited 26 ADPKD patients (Group A) with modestly impaired renal function (eGFR 45-70 ml/min/1.73m2), 26 age- and sex-matched ADPKD patients (Group B) with relatively preserved renal function (eGFR)>70 ml/min/1.73m2), and 26 age- and sex-matched controls (Group C). Determination of circulating levels of ADMA, 15-F2t-Isoprostane, oxidized-LDL and routine biochemistry was performed. Results: Group A and B had significantly higher ADMA levels as compared to controls (1.68±0.7 vs 0.51±0.2 μmol/l, P2t-IsoP and oxidized-LDL levels were also significantly higher in Group B relative to controls (788.8±185.0 vs 383.1±86.0 pgr/ml, P2t-Isoprostane (r=0.811, PConclusion: This study shows elevation in circulating levels of ADMA along with aggravation of oxidative stress from the early stages of ADPKD. 
546 |a EN 
690 |a ADPKD 
690 |a Asymmetric dimethylarginine 
690 |a ADMA 
690 |a autosomal dominated polycystic kidney disease 
690 |a eGFR 
690 |a Oxidative stress 
690 |a Dermatology 
690 |a RL1-803 
690 |a Diseases of the circulatory (Cardiovascular) system 
690 |a RC666-701 
690 |a Diseases of the genitourinary system. Urology 
690 |a RC870-923 
655 7 |a article  |2 local 
786 0 |n Kidney & Blood Pressure Research, Vol 38, Iss 1, Pp 72-82 (2014) 
787 0 |n http://www.karger.com/Article/FullText/355756 
787 0 |n https://doaj.org/toc/1420-4096 
787 0 |n https://doaj.org/toc/1423-0143 
856 4 1 |u https://doaj.org/article/bca5a07d6ae64e8a9f16a3f115e4d795  |z Connect to this object online.